¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immune adherence hemagglutination assay"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® immune system ÇÑ±Û ¸é¿ªÃ¼°è
¼³¸í   
  ¼¼Æ÷¼ººÐ ¹× ºÐÀÚ¼ººÐÀÇ º¹ÇÕü°è·Î¼­, ÀÌÀÇ ÀÏÂ÷±â´ÉÀº ÀÚ±â(self)¸¦ ºñÀÚ±â(not self)·ÎºÎÅÍ ±¸º°ÇÏ°í ¿ÜºÎ»ý¹° ¶Ç´Â ¹°Áú¿¡ ´ëÇØ ¹æ¾îÇϴ °ÍÀÌ´Ù. ÀÏÂ÷ÀûÀΠ¼¼Æ÷¼ººÐÀº ¸²ÇÁ±¸¿Í Å«Æ÷½Ä¼¼Æ÷À̸ç ÀÏÂ÷ÀûÀΠºÐÀÚ¼ººÐÀº Ç×ü¿Í ¸²Æ÷Ä«ÀÎÀÌ´Ù.
  
  
¿µ¹® enzyme-linked immunoabsorbent assay ÇÑ±Û È¿¼Ò¸é¿ªÃøÁ¤¹ý
¼³¸í   
  È¿¼Ò°áÇո鿪ÈíÂøÁ¦ °ËÁ¤¹ýÀ¸·Î ¹ø¿ªµÇ°í ÀÖ´Ù. ÀÌ ¹ýÀº Ç׿ø(¶Ç´Â Ç×ü)¿¡ ¾ËÄ®¸® Æ÷½ºÆÄŸ¾ÆÁ¦ ¶Ç´Â Æä¸£¿Á½Ãµð¾ÆÁ¦ µîÀÇ »ê¼Ò¸¦ °áÇÕ½ÃÄÑ µÎ°í ±× »ê¼ÒȰ¼ºÀ» ÁöÇ¥·Î »ï¾Æ Ç׿øÇ×ü¹ÝÀÀÀÇ Á¤µµ¸¦ ¾È ´ÙÀ½ ¿©±â¿¡¼­ Ç׿ø(¶Ç´Â Ç×ü)ÀÇ ¾çÀ» ±¸Çϴ °ÍÀÌ´Ù. ÀÌ ¹ýÀÇ ÀÌÁ¡À¸·Î¼­ °í°¨µµ, Á¶ÀÛÀÇ °£´ÜÇÔ ¹× ¹æ»ç¼±¸é¿ªÃøÁ¤¹ýó·³ ¹æ»ç¼º¹°ÁúÀ» »ç¿ëÇÏÁö ¾Ê¾Æµµ µÈ´Ù´Â Á¡À» µé ¼ö ÀÖ´Ù. È£¸£¸óÀ̳ª ¸é¿ª±Û·ÎºÒ¸°ÀÇ Á¤·®¹ýÀ¸·Î¼­ ÀÀ¿ë µÇ°í ÀÖÀ¸¸ç ÃøÁ¤¿ë Å°Æ®µµ ½ÃÆÇµÇ°í ÀÌÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune adherence hemagglutination
    ¸é¿ªºÎÂøÀûÇ÷±¸ÀÀÁý
  • immune adherence
    ¸é¿ªºÎÂø
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ
  • hemagglutination assay
    Ç÷±¸ÀÀÁý°Ë»ç
  • adherence
    ºÎÂø, À¯Âø
  • adherence protein
    ºÎÂø´Ü¹éÁú
  • hemagglutination
    ÀûÇ÷±¸ÀÀÁý, Ç÷±¸ÀÀÁý
  • hemagglutination inhibition antibody
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦Ç×ü
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦°Ë»ç
  • hemagglutination-inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ
  • indirect hemagglutination
    °£Á¢ÀûÇ÷±¸ÀÀÁý
  • passive hemagglutination
    ¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • viral hemagglutination
    ¹ÙÀÌ·¯½ºÀûÇ÷±¸ÀÀÁý
  • antibody capture enzyme-linked immunosorbent assay
    Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤(¹ý)
  • antigen capture assay
    Ç׿øÆ÷È¹ÃøÁ¤
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adherence protein
    ºÎÂø´Ü¹é
  • immune thrombocytopenic purpura
    ¸é¿ªÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ý
  • hemagglutination
    ÀûÇ÷±¸ÀÀÁý
  • hemagglutination test
    Ç÷±¸ÀÀÁý½ÃÇè, Ç÷±¸ÀÀÁý°Ë»ç
  • assay
    ºÐ¼®, ÃøÁ¤
  • enzyme-linked immunosorbent assay
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • Treponema pallidum hemaggulutination assay
    ¸Åµ¶Ç÷±¸ÀÀÁý°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune adherence hemagglutination
    ¸é¿ªºÎÂøÀûÇ÷±¸ÀÀÁý
  • immune adherence
    ¸é¿ªºÎÂø
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ
  • hemagglutination assay
    Ç÷±¸ÀÀÁýÃøÁ¤(¹ý)
  • adherence
    ºÎÂø
  • adherence protein
    ºÎÂø´Ü¹é
  • hemagglutination inhibition antibody
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦Ç×ü
  • hemagglutination
    ÀûÇ÷±¸ÀÀÁý
  • hemagglutination test
    Ç÷±¸ÀÀÁý½ÃÇè, Ç÷±¸ÀÀÁý°Ë»ç
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦°Ë»ç
  • hemagglutination-inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ
  • indirect hemagglutination
    °£Á¢ÀûÇ÷±¸ÀÀÁý¹ý
  • passive hemagglutination
    ¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • reversed passive hemagglutination
    ¿ª¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • sensitized hemagglutination
    ¹Î°¨ÀûÇ÷±¸ÀÀÁý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hemagglutination, immune adherence
    ¸é¿ªºÎÂø Ç÷±¸ÀÀÁý
  • immune adherence hemagglutination
    ¸é¿ªºÎÂø Ç÷±¸ÀÀÁý
  • immune adherence
    ¸é¿ªºÎÂø(Øóæ¹Üõó·).
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ.
  • adherence
    ºÎÂø, Á¢Âø
  • adherence
    Á¤Âø(ïÒó·)
  • adherence
    À¯Âø,ºÎÂø, Á¢Âø
  • adherence syndrome, Johnson
    ÁÔ½¼À¯ÂøÁõÈıº
  • glass adherence
    À¯¸®ºÎÂø.
  • HA= hemagglutination
    ÀûÇ÷±¸ÀÀÁý(¹ÝÀÀ).
  • HIT= hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè.
  • hemagglutination
    (Àû)Ç÷±¸ÀÀÁý(¹ÝÀÀ)
  • hemagglutination
    Ç÷±¸ÀÀÁý
  • hemagglutination =HA
    ÀûÇ÷±¸ÀÀÁý(¹ÝÀÀ)(îåúìϹëêó¢Úãëë).
  • hemagglutination =HA
    (Àû)Ç÷±¸ÀÀÁý(¹ÝÀÀ)(ËøÌ´Ë´Ëô̤ËÑËô).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hemagglutination, immune adherence
    ¸é¿ªºÎÂø Ç÷±¸ÀÀÁý
  • immune adherence hemagglutination
    ¸é¿ªºÎÂø Ç÷±¸ÀÀÁý
  • immune adherence
    ¸é¿ªºÎÂø(Øóæ¹Üõó·).
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ.
  • treponema pallidum immune adherence test =tpia
    Æ®·¹Æ÷³×¸¶¸é¿ªºÎÂø½ÃÇè
  • adherence
    À¯Âø,ºÎÂø, Á¢Âø
  • adherence
    ºÎÂø, Á¢Âø
  • adherence
    Á¤Âø(ïÒó·)
  • adherence syndrome, Johnson
    ÁÔ½¼À¯ÂøÁõÈıº
  • glass adherence
    À¯¸®ºÎÂø.
  • leukocyte,adherence defects
    À¯Âø°á¼Õ(ë¨ó·ÌÀáß)
  • nylon wool adherence procedure
    ³ªÀϷоç¸ð<--ÅÐ>ºÎÂø¹ý
  • hemagglutination
    Ç÷±¸ÀÀÁý
  • hemagglutination
    (Àû)Ç÷±¸ÀÀÁý(¹ÝÀÀ)
  • hemagglutination =HA
    (Àû)Ç÷±¸ÀÀÁý(¹ÝÀÀ)(ËøÌ´Ë´Ëô̤ËÑËô).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Immune cause (Hemolytic anemia)
    ¸é¿ª¿øÀÎ(¿ëÇ÷¼ººóÇ÷)
    [¿¾ ¿ë¾î] ¸é¿ª¼º¿øÀÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adherence protein
    ºÎÂø´Ü¹éÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune adherence
    ¸é¿ª ºÎÂø(Øóæ¹Ý¾ó·)
  • hemagglutination
    "(Àû,îå)Ç÷±¸(úìϹ) ÀÀÁý(ëêó¢)"
  • hemagglutination inhibition
    "(Àû,îå)Ç÷±¸(úìϹ) ÀÀÁý ÀúÇØ(ëêó¢îÁúª)"
  • passive hemagglutination
    ¼öµ¿ Ç÷¾×ÀÀÁý(áôÔÑúìäûëêó¢)
  • hemolytic immune body
    ¿ëÇ÷ ¸é¿ªÃ¼(éÁúìØóæ¹ô÷)
  • immune adsorbent
    ¸é¿ª ÈíÂøÁ¦(Øóæ¹ýåó·ð¥)
  • immune antibody
    ¸é¿ª Ç×ü(Øóæ¹ù÷ô÷)
  • immune clearance
    ¸é¿ª ûÁ¤(Øóæ¹ôèïä)
  • immune competent cell
    ¸é¿ª Àû°Ý ¼¼Æ÷(Øóæ¹îêÌ«á¬øà)
  • immune complex
    ¸é¿ª º¹ÇÕü(Øóæ¹ÜÜùêô÷)
  • immune conglutination
    ¸é¿ª À¯Âø ¹ÝÀÀ(Øóæ¹ë¨ó·Úãëë)
  • immune conglutinin
    ¸é¿ª(Øóæ¹)ÄÜ±Û·çÆ¼´Ñ
  • immune cytolysis
    ¸é¿ª ¼¼Æ÷¿ëÇØ(Øóæ¹á¬øàéÁú°)
  • immune deficincy disease
    ¸é¿ª °áÇÌ Áúȯ(Øóæ¹ÌÀù¹òðü´)
  • immune elimination
    ¸é¿ª À̹° Á¦°Å(Øóæ¹ì¶Úªð¶ËÛ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
  • immune
    ¸é¿ª¼ºÀÇ
  • assay
    Á¤·®, ¿ª°¡°ËÁ¤, È¿·Â°ËÁ¤
  • ELISA [=enzyme-linked immunosorbent assay]
    ELIZA, ¿¤¸®ÀÚ
  • enzyme-linked immunosorbent assay [=ELISA]
    ELISA, ¿¤¸®ÀÚ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IAHA idiopathic autoimmune hemolytic anemia; immune adherence hemagglutination
LAI assay Leukocyte Adherence Inhibition assay
IA ibotenic acid; immune adherence; immunoadsorbent; immunobiologic activity; impedance angle; indolami...
RCIA red cell immune adherence
TPIA Treponema pallidum immune adherence
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IAHA Immune adherence hemagglutination
IHA Indirect Hemagglutination assay
IA Immune Adherence
HIT Hemagglutination inhibition test
PHA Passive hemagglutination assays
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bacterial adherence
    ¼¼±Õ Á¢Âø¼º
  • disc-articular surface adherence
    °üÀý¿øÆÇ-°üÀý ¸é À¯Âø
  • hemagglutination
    ÀûÇ÷±¸ ÀÀÁý ¹ÝÀÀ
    Ç×ü¿¡ ÀÇÇØ »ý±â´Â °æ¿ì¿Í ¾î¶² Á¾·ùÀÇ ¹ÙÀÌ·¯½º ÀÔÀÚ¿¡ ÀÇÇÑ °æ¿ì ȤÀº °íºÐÀÚ µ¦½ºÆ®¶õ °°Àº ¹°Áú¿¡ ÀÇÇÑ °æ¿ì µîÀÌ ÀÖ´Ù.
  • hemagglutination inhibition test
    ÀûÇ÷±¸ ÀÀÁý ¾ïÁ¦ ½ÃÇè
  • indirect hemagglutination
    °£Á¢ Ç÷±¸ ÀÀÁý ¹ÝÀÀ
    ¼öµ¿ÀûÀ¸·Î Ç¥¸é¿¡ ÈíÂø½ÃŰ°Å³ª ¼¼Æ÷¿¡ È­ÇÐÀûÀ¸·Î °áÇÕ½ÃŲ Ç׿ø°ú ƯÀÌÇ×ü »çÀÌÀÇ ¹ÝÀÀ¿¡ ÀÇÇÑ ÀûÇ÷±¸ÀÇ ÀÀÁý.
  • passive hemagglutination
    Çǵ¿¼º ÀûÇ÷±¸ ÀÀÁý
  • viral hemagglutination
    ¹ÙÀÌ·¯½º Ç÷±¸ ÀÀÁý¹ý
  • virus hemagglutination inhibitor
    ¹ÙÀÌ·¯½º ÀûÇ÷±¸ ÀÀÁý¹ÝÀÀ ¾ïÁ¦ ÀÎÀÚ
  • acid phosphatase assay
    »ê¼º Æ÷½ºÆÄŸÁ¦ ÃøÁ¤
  • antigenic assay
    Ç׿ø¼º ºÐ¼®
  • antimicobial assay
    Ç×±ÕÁ¦ ÃøÁ¤
  • assay
    Á¤·®, ¿ª°¡ °ËÁ¤, È¿·Â °ËÁ¤
    È¥ÇÕ¹°¿¡ ÀÖ´Â ¼ººÐÀÇ ¾ç, ¶Ç´Â ¾à¹°ÀÇ »ý¹°ÇÐÀû, ¾à¸®ÇÐÀû ¿ª°¡ µîÀÇ ÃøÁ¤.
  • calcitonin assay
    Ä®½ÃÅä´Ñ ÃøÁ¤
  • carcinoembryonic antigen assay
    ¾Ï ¹è¾Æ¼º Ç׿ø ÃøÁ¤, ¾Ï¼º ¹è¾Æ¼º Ç׿ø ÃøÁ¤
  • carcinogen assay
    ¹ß¾Ï ¹°Áú °Ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
leukocyte adherence assay test A test to detect the ability of leukocytes to adhere to bacteria, performed in vitro using nylon fibres to measure adherence.
(05 Mar 2000)
immune adherence The binding of antigen-antibody complexes or cells coated with antibodies or complement to cells bearing the appropriate complement or Fc receptors.
(05 Mar 2000)
immune adherence phenomenon A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex.
Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon.
(05 Mar 2000)
immune adherence reaction A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound c3 molecules on the c3b receptor sites of the indicator cell.
(12 Dec 1998)
hemagglutination <haematology> Agglutination of red blood cells, often used to test for the presence of antibodies directed against red cell surface antigens or carbohydrate binding proteins or viruses in a solution. Requires that the agglutinin has at least two binding sites.
(18 Nov 1997)
adherence Refers to the ability of bacteria adhere (stick) to host surfaces.
(09 Oct 1997)
adherence syndrome <syndrome> Restriction action of an ocular muscle owing to adhesions between the muscle and its fascial sheath.
(05 Mar 2000)
red cell adherence phenomenon A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex.
Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon.
(05 Mar 2000)
red cell adherence test The diagnostic application of the immune adhesion phenomenon.
Synonym: erythrocyte adherence test, immune adhesion test, red cell adherence test.
(05 Mar 2000)
guideline adherence Conformity in fulfilling or following official, recognised, or institutional requirements, guidelines, recommendations, protocols, pathways, or other standards.
(12 Dec 1998)
erythrocyte adherence phenomenon A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex.
Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon.
(05 Mar 2000)
leukocyte adherence inhibition test Test for cell-mediated antitumour immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumours of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumour-bearing patients block the lai reaction of their own leukocytes or those of other patients with the same type of tumour.
(12 Dec 1998)
acetyl reduction assay <investigation> A technique for measuring the nitrogen fixation activity in photosynthetic organisms. It uses a flame ionisation detector and a gas chromatography apparatus to determine the reduction of acetylene to ethylene by the enzyme nitrogenase.
(06 May 1997)
Ames assay <procedure> One of a number of procedures used to test substances for likely ability to cause cancer that combines the use of animal tissue to generate active metabolites of the substance with a test for mutagenicity in bacteria.
(18 Nov 1997)
antibiotic assay <investigation> A test to determine how sensitive a bacterial or fungal strain is to arange of antibiotics bymeasuring the microbes' ability to grow in astandard dilution of each chemical.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adherence
    ºÎÂø
  • assay
    ½Ã±ÝÇÏ´Ù; ºÐ¼®ÇÏ´Ù
  • adherence
    °í¼ö;ÁýÂø;Ãæ½Ç;ÁöÁö(=ADHESION 1)
  • assay
    ½Ã±Ý;½Ã±ÝÇÏ´Ù;ºÐ¼®;ºÐ¼®ÇÏ´Ù;½ÃÇè;½ÃÇèÇÏ´Ù;ºÐ¼®¹°
  • immune
    ¸é¿ªÀÇ
  • immune
    ¸é¿ªÀÇ;(Àü¿°º´,º´µ¶µîÀ»)¸éÇÑ;¸é¿ª¼ºÀÇ(to,from);(°ú¼¼,°ø°Ý µî¿¡¼­);¸éÁ¦µÈ(exempt);(..À») ´çÇÒ ¿°·Á°¡ ¾ø´Â(from,against);(¿¡)µ¿ÇÏÁö ¾Ê´Â;¿µÇâÀ» ¹ÞÁö ¾Ê´Â(to);¸é¿ª(¸éÁ¦)ÀÚ
  • immune body
    ¸é¿ªÃ¼;Ç×ü(antibody)
  • immune complex
    ¸é¿ª º¹ÇÕü
  • immune response
    ¸é¿ª ÀÀ´ä;¸é¿ª ¹ÝÀÀ
  • immune serum
    ¸é¿ª Ç÷û
  • immune surveillance
    IMMUNOLOGICAL SURVEILLANCE
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á